Original Research

Published on 26 Jul 2022

SP1-Induced Upregulation of lncRNA LINC00659 Promotes Tumour Progression in Gastric Cancer by Regulating miR-370/AQP3 Axis

in Cancer Endocrinology

Yao Wang
Yuanyuan Guo
Tianchi Zhuang
Ting Xu
Minghui Ji

Frontiers in Endocrinology

doi 10.3389/fendo.2022.936037

2,431 views
12 citations

Original Research

Published on 26 Jul 2022

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma

in Cancer Endocrinology

Liping Liang
Shijie Mai
Genghui Mai
Ye Chen
Le Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2022.882431

3,617 views
3 citations

Original Research

Published on 22 Jul 2022

Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma

in Cancer Endocrinology

Huan Zhang
Xiangqian Zheng
Juntian Liu
Ming Gao
Biyun Qian

Frontiers in Endocrinology

doi 10.3389/fendo.2022.896121

2,632 views
3 citations

Original Research

Published on 21 Jul 2022

Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors

in Cancer Endocrinology

Yibo Cai
Zhuo Liu
Lai Jiang
Dening Ma
Zhenyuan Zhou
Haixing Ju
Yuping Zhu

Frontiers in Endocrinology

doi 10.3389/fendo.2022.871830

2,775 views
7 citations

Original Research

Published on 19 Jul 2022

Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019

in Cancer Endocrinology

Saeid Safiri
Seyed Aria Nejadghaderi
Nahid Karamzad
Jay S. Kaufman
Kristin Carson-Chahhoud
Nicola Luigi Bragazzi
Mark J. M. Sullman
Mohammad Reza Beyranvand
Mohammad Ali Mansournia
Amir Almasi-Hashiani

Frontiers in Endocrinology

doi 10.3389/fendo.2022.879890

5,802 views
18 citations

Original Research

Published on 18 Jul 2022

Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results

in Cancer Endocrinology

Qiang Chen
Yang Liu
Wei Lu
Lingyun Zhang
Anping Su
Feng Liu
Jingqiang Zhu

Frontiers in Endocrinology

doi 10.3389/fendo.2022.921845

9,909 views
5 citations

Original Research

Published on 18 Jul 2022

Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study

in Cancer Endocrinology

Zhen Yang
Dongsheng Zhang
Guangjun Shi

Frontiers in Endocrinology

doi 10.3389/fendo.2022.928341

2,348 views
4 citations

Original Research

Published on 15 Jul 2022

Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma

in Cancer Endocrinology

Hui Huang
Jie Liu
Xiaolei Wang
Shaoyan Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2022.941080

1,883 views
4 citations

Original Research

Published on 15 Jul 2022

Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis

in Cancer Endocrinology

Qungang Chang
Jieming Zhang
Yaqian Wang
Hongqiang Li
Xin Du
Daohong Zuo
Detao Yin

Frontiers in Endocrinology

doi 10.3389/fendo.2022.937049

3,263 views
14 citations

Original Research

Published on 14 Jul 2022

Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis

in Cancer Endocrinology

Youwen Zhu
Kun Liu
Kailing Wang
Libo Peng

Frontiers in Endocrinology

doi 10.3389/fendo.2022.909333

3,756 views
10 citations

Review

Published on 14 Jul 2022

The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity

in Cancer Endocrinology

William K. Storck
Allison M. May
Thomas C. Westbrook
Zhi Duan
Colm Morrissey
Joel A. Yates
Joshi J. Alumkal

Frontiers in Endocrinology

doi 10.3389/fendo.2022.926585

6,228 views
14 citations

Original Research

Published on 13 Jul 2022

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment

in Cancer Endocrinology

Ewald Jan Doornebal
Nicola Harris
Antonio Riva
Ravi Jagatia
Michail Pizanias
Andreas Prachalias
Krishna Menon
Melissa Preziosi
Ane Zamalloa
Rosa Miquel

Frontiers in Endocrinology

doi 10.3389/fendo.2022.909180

3,159 views
6 citations

Mini Review

Published on 12 Jul 2022

Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead

in Cancer Endocrinology

Swayamjeet Satapathy
Chandrasekhar Bal

Frontiers in Endocrinology

doi 10.3389/fendo.2022.924841

4,751 views
5 citations

Systematic Review

Published on 11 Jul 2022

Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials

in Cancer Endocrinology

Zhiyang Li
Jiehua Zheng
Zeqi Ji
Lingzhi Chen
Jinyao Wu
Juan Zou
Yiyuan Liu
Weixun Lin
Jiehui Cai
Yaokun Chen

Frontiers in Endocrinology

doi 10.3389/fendo.2022.939048

7,699 views
4 citations

Methods

Published on 11 Jul 2022

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines

in Cancer Endocrinology

Daqi Zhang
Carla Colombo
Hui Sun
Hoon Yub Kim
Antonella Pino
Simone De Leo
Giacomo Gazzano
Luca Persani
Gianlorenzo Dionigi
Laura Fugazzola

Frontiers in Endocrinology

doi 10.3389/fendo.2022.875875

3,439 views
10 citations

Review

Published on 08 Jul 2022

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

in Cancer Endocrinology

Ivana Puliafito
Francesca Esposito
Angela Prestifilippo
Stefania Marchisotta
Dorotea Sciacca
Maria Paola Vitale
Dario Giuffrida

Frontiers in Endocrinology

doi 10.3389/fendo.2022.860671

7,683 views
18 citations

Navigation group

Articles

SP1-Induced Upregulation of lncRNA LINC00659 Promotes Tumour Progression in Gastric Cancer by Regulating miR-370/AQP3 Axis

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma

Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma

Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors

Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019

Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results

Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study

Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma

Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis

Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis

The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment

Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead

Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects